Regulatory Roles of the Gut Microbiota in Hematological Malignancies
International Journal of Molecular Sciences · 18.11.2026 · 27 (22) · 10377
DOI: 10.3390/ijms272210377 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.11.2026. Verfasst von Xiaoxuan Liu und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Research Project of Biomedicine and Health Laboratory in Shanxi Province, Shenzhen Medical Research Fund, Nanshan District medical key discipline construction financial support project.
Abstract (Originalsprache)
Relying on the proposed gut–bone marrow bidirectional regulatory axis, the gut microbiota may influence systemic immune homeostasis and the bone marrow hematopoietic microenvironment through maintenance of the mucosal barrier and signaling molecules such as short-chain fatty acids and tryptophan metabolites, and may thereby contribute to the pathobiology of hematological malignancies. Patients with hematological malignancies often exhibit dysbiosis, including decreased gut microbial diversity, the depletion of butyrate-producing beneficial bacteria, and the overproliferation of opportunistic pathogens, although patterns vary across cohorts. This dysbiosis may contribute to malignant clonal expansion and disease progression and has been associated with variation in the response to chemotherapy and cellular therapy and with the risk of graft-versus-host disease, severe infections, and intestinal mucositis following allogeneic hematopoietic stem cell transplantation. This narrative review summarizes interactions between the gut microbiota and hematological malignancies, disease-associated microbiota profiles, treatment-related associations, and barriers to clinical translation. Because much of the human evidence is observational, microbiota-directed interventions require prospective validation before routine clinical use.
Förderung
- Open Research Project of Biomedicine and Health Laboratory in Shanxi Province
- Shenzhen Medical Research Fund
- Nanshan District medical key discipline construction financial support project
Zitieren
APA
Liu, X., & Guo, Z. (2026). Regulatory Roles of the Gut Microbiota in Hematological Malignancies. International Journal of Molecular Sciences, 27(22), 10377. https://doi.org/10.3390/ijms272210377
Vancouver
Liu X, Guo Z. Regulatory Roles of the Gut Microbiota in Hematological Malignancies. International Journal of Molecular Sciences. 2026;27(22):10377. doi:10.3390/ijms272210377
BibTeX
@article{Liu2026,
author = {Liu, Xiaoxuan and Guo, Zhi},
title = {Regulatory Roles of the Gut Microbiota in Hematological Malignancies},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10377},
doi = {10.3390/ijms272210377}
}
EUVIMED